Global Tissue Microarray Market Overview: Trends Shaping Growth to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Tissue Microarray Industry In 2025?

The overall valuation of the tissue microarray sector has seen considerable growth over the past few years, with projections indicating an expansion from USD 12.05 billion in 2024 to USD 13.11 billion by the following year, reflecting an 8.8% compound annual growth rate; this positive trajectory during the historical period is largely fueled by the increasing adoption of personalized medicine approaches, vigorous drug research and development activities, the demand for more streamlined analytical processes, the escalating incidence of long-term illnesses, and the expansion of biobanking efforts worldwide.

The tissue microarray sector anticipates a swift expansion in the coming years, projecting a valuation of $20.85 billion by 2029, fueled by a compound annual growth rate (CAGR) reaching 12.3 percent. This trajectory throughout the projection timeframe is powered by the rise of digital pathology, broader utilization across various fields, the expansion of the biopharmaceutical sector, the establishment of regulatory endorsements and uniform guidelines, and the incorporation of artificial intelligence alongside machine learning. Key movements defining this period involve innovations in visual data capture methods, the creation of three-dimensional tissue microarrays, implementation of high-content screening protocols, efforts aimed at establishing industry standards, and the integration of single-cell analysis techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

Which Major Market Drivers Are Shaping The Future Of The Tissue Microarray Market?

Anticipated escalation in cancer prevalence is set to fuel the expansion of the tissue microarray sector moving ahead. This disease category, characterized by the uncontrolled multiplication of abnormal cells that breach normal limitations and subsequently infiltrate adjacent structures or disseminate to distant sites, can manifest in any bodily organ or tissue. In the field of oncology, tissue arrays serve as vital tools for assessing the presence of cancer-relevant biomarkers across diverse tumor specimens. To illustrate this trend, data released in June 2022 by Macmillan Cancer Support, a charitable organization in the UK focusing on cancer, indicated that the population afflicted by cancer reached 3 million in that year, with forecasts suggesting this figure will climb towards 3.5 million by 2025 and further to 4 million by the close of 2030 within the United Kingdom; consequently, this increasing incidence of cancer constitutes a primary impetus behind the market growth for tissue microarrays.

What Are The Major Segment Types Covered In The Tissue Microarray Market?

The tissue microarraymarket covered in this report is segmented –

1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

Subsegments:

1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

What Key Innovation Trends Are Fueling Advancements In The Tissue Microarray Market?

A significant and escalating trend within the arena of tissue microarray technology involves forging strategic alliances, wherein numerous prominent entities within this sector are actively engaging in collaborations designed to pioneer novel tissue microarray advancements through joint efforts. Illustratively, in November of 2022, The Cureline Group, a United States-based contract research organization specializing in precision and translational medicine, offering laboratory and HBS biobanking support, entered into a collaborative agreement with Cellecta Inc., an American firm supplying both RNAi and CRISPR screening products and associated services; this union established the Tissue 2 Target Services, a fresh strategic compact intended to meld the core proficiencies of both organizations in the domain of molecular analysis concerning cells and tissues alongside human biospecimen stewardship, ultimately furnishing pre-clinical and translational research operations with specialized gene target and biomarker identification capabilities designed for streamlined operational processes. Adding to this, a separate development occurred in September 2022 when Ultivue Inc., an American biotechnology company focused on creating reagent-driven solutions that maximize the biological insights extracted from tissue and cellular specimens, linked up with ngTMA, which operates as the Translational Research Unit platform based in Switzerland for the University of Bern and concentrates on innovating tissue microarray fabrication workflows; the objective of this specific partnership is to propel multiplexed immunofluorescence (mIF) assays forward and integrate emerging TMA methodologies to facilitate spatial analysis in scientific investigations, thereby elevating the standard of TMAs utilized presently in both clinical and translational research settings.

Which Key Players Are Driving Competition In The Tissue Microarray Market?

Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

What Regional Growth Trends Are Shaping The Tissue Microarray Market Outlook?

North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tissue Microarray Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

Browse Through More Reports Similar to the Global Tissue Microarray Market 2025, By The Business Research Company

Diagnostic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diagnostic-equipment-global-market-report

Computer Peripheral Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computer-peripheral-equipment-global-market-report

Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795